Identity
- Trade Name
- UroVysion FDA UDI
- Generic Name
- Bladder tumour-associated mutation IVD, control FDA UDI
- Device Name
- ProbeChek UroVysion Bladder Cancer Kit Control Slides FDA UDI
- Model / Reference
- 02J27-011 FDA UDI
- Description
- ProbeChek UroVysion Bladder Cancer Kit Control Slides FDA UDI
Identifiers
- Catalog Number
- 02J27-011 FDA UDI
- Primary DI / UDI-DI
- 00884999002128 FDA UDI
- FDA Product Code
- OYU FDA UDI
- GMDN Term
- Bladder tumour-associated mutation IVD, control FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 866.4700 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Bladder tumour-associated mutation IVD, control
UroVysion by Abbott Molecular — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Abbott Molecular
Sources (1)
- FDA UDI 4a36fd6c-30da-4dc2-95f5-08a4217c12bb 36 fields · synced May 30, 2026